Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-25, Stock:JNJ, The news for the past five days is as follows:
2019-04-17: NEWS1: 10 Best Stocks to Buy and Hold Forever.NEWS2: 10 Best Stocks to Buy and Hold Forever.NEWS3: Stock Market News For Apr 17, 2019.NEWS4: Stock Market News For Apr 17, 2019.NEWS5: Edited Transcript of JNJ earnings conference call or presentation 16-Apr-19 12:30pm GMT.NEWS6: Liability Issues Weigh on Johnson & Johnson.NEWS7: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS8: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS9: Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative.NEWS10: Stock Market News For Apr 17, 2019.NEWS11: StockBeat - UnitedHealth Deepens Losses as Fears Over Political Risk Rise.NEWS12: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.NEWS13: Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN.NEWS14: Is More Downside Ahead for Boeing Stock? Should You Buy?.NEWS15: Dow stock that&apos;s lost $34 billion in market cap in the last week could be a buy, says investor.NEWS16: Dow stock that's lost $34 billion in market cap in the last week could be a buy, says investor.NEWS17: 5 takeaways from Johnson & Johnson’s first-quarter results.NEWS18: Why The Rally In Johnson & Johnson Stock May Top Out At $150.NEWS19: Solid Drug Sales, Cost Control Boost Johnson & Johnson.NEWS20: Why ‘Scared’ Investors May Push Health Care Stocks Even Lower.NEWS21: Asian shares edge lower despite encouraging China GDP data.
2019-04-18: NEWS1: Be Careful With Healthcare Stocks Here.NEWS2: Checking in on trade war's impact on the markets.NEWS3: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS4: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS5: Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion.NEWS6: Here Are the Key Takeaways From J&J's Q1 Earnings Report.NEWS7: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS9: You can capture a dividend above 5% and still enjoy stock-market growth.NEWS10: Idorsia confirms 2019 spending plan as clinical trials "on track".
2019-04-22: NEWS1: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS2: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS3: Beauty: A Key Growth Driver of JNJ’s Consumer Segment in Q1.NEWS4: What Are Analysts Recommending for Johnson & Johnson?.NEWS5: JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs.NEWS6: JNJ Surpassed Consensus Estimates in the First Quarter.NEWS7: Miguel Patricio: 10 Things to Know About the New Kraft Heinz CEO.NEWS8: 6 Cannabis Execs On The Strengths Of Their Businesses.NEWS9: JNJ or PFE: Comparing Their Fastest-Growing Immunology Drugs.NEWS10: JNJ or PFE: Comparing Fastest Growing Immunology Drugs.NEWS11: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS13: JNJ or PFE: Which Has Better EPS Guidance for 2019?.NEWS14: JNJ or PFE: Who has a Stronger EPS Guidance for Fiscal 2019?.NEWS15: JNJ or PFE: Who has a Stronger Revenue Guidance for Fiscal 2019?.
2019-04-23: NEWS1: Cramer's lightning round: I'm sticking with this gold stock pick.NEWS2: Cramer's lightning round: I'm sticking with this gold stock pick.NEWS3: Prescription for Success?.NEWS4: Prescription for Success?.NEWS5: Pharmaceutical Segment: A Key Revenue Driver for JNJ in Q1.NEWS6: Prescription for Success?.NEWS7: Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN.NEWS9: JNJ’s Consumer Business: International Market Trends in Q1.NEWS10: JNJ’s OTC, Oral Care, and Wound Care Businesses: Key Trends in Q1.
2019-04-24: NEWS1: Johnson & Johnson to Host Pharmaceutical Business Review.NEWS2: 7 Companies With Unacceptable CEO-Worker Wage Gaps.NEWS3: 7 Companies With Unacceptable CEO-Worker Wage Gaps.NEWS4: Everything You Need to Know About Investing in Healthcare.NEWS5: Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales.NEWS6: Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales.NEWS7: Approach Microsoft Stock Cautiously as it Goes Into Earnings.NEWS8: Approach Microsoft Stock Cautiously as it Goes Into Earnings.NEWS9: 7 Companies With Unacceptable CEO-Worker Wage Gaps.NEWS10: Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales.NEWS11: Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Approach Microsoft Stock Cautiously as it Goes Into Earnings.NEWS14: Jim Cramer Gives His Opinion On Barrick Gold, Canopy Growth, EA, Johnson & Johnson And More.NEWS15: Exploring JNJ’s Key Oncology Assets in the First Quarter.

Answer: Rise